Bright Light Therapy on Sleep Health in Lung Cancer Patients

Part of paid clinical trials in Detroit, Michigan.

Sponsor
Henry Ford Health System
Study ID
NCT07064395
Status
Recruiting
Apply to this trial

Conditions

  • Lung Cancers

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • bright light — OTHER
    Lung cancer patients in the bright light arm will receive 12,000 lux bright light through light visor for 4 weeks.

Study Details

The goal of this randomized intervention trial is to determine the effect of bright light therapy on sleep disturbance, as well as to investigate the impacts of bright light therapy on biological age measured by clinical biomarkers. The main questions it aims to answer are: * Does bright light therapy improve sleep patterns (i.e., sleep onset latency, sleep disturbance, and sleep efficiency) in lung cancer patients? * Can bright light therapy slow the rate of aging measured by biological age in lung cancer patients? Researchers will compare bright light therapy group to control group to see if bright light works to reduce sleep disturbance and decelerate biological aging. Participants will: * Receive bright light exposure or usual light exposure every day for 4 weeks * Get blood draw at the baseline and at 4 weeks for clinical biomarkers tests * Complete self-reported sleep, fatigue and stress surveys at the baseline and at 4 weeks * Keep a daily sleep log

Key Dates

Start date
Jun 9, 2025
Status verified
Jun 2025
Primary completion
Feb 28, 2026
Completion
Feb 28, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: bright light arm
    Participants will receive a daily 30-minutes bright light through light visor for 4 weeks.
  • No Intervention: control arm
    Participants will not receive bright light, and keep their usual daily light exposure for 4 weeks.

Primary Outcome Measure

Change from Baseline in sleep patterns at 4 weeks [ Time Frame: from enrollment to the end of the intervention at 4 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Henry Ford Health SystemDetroitMichigan48202-

Find similar trials in Detroit, MI

By research site
Henry Ford Health System· Detroit, MI

Related Studies